Cargando…

Dramatic, durable response to therapy in gBRCA2-mutated pancreas neuroendocrine carcinoma: opportunity and challenge

Poorly differentiated pancreatic neuroendocrine tumors (PDNEC), are a subtype of pancreatic cancer encompassing both small cell and large cell neuroendocrine carcinoma subtypes, and are characterized as distinct in terms of biology and prognosis compared to the more common pancreatic adenocarcinoma....

Descripción completa

Detalles Bibliográficos
Autores principales:	Keane, Fergus, Bajwa, Raazi, Selenica, Pier, Park, Wungki, Roehrl, Michael H., Reis-Filho, Jorge S., Mandelker, Diana, O’Reilly, Eileen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122663/ https://www.ncbi.nlm.nih.gov/pubmed/37087482 http://dx.doi.org/10.1038/s41698-023-00376-x

Ejemplares similares

Pancreatic Cancer: BRCA Targeted Therapy and Beyond
por: Keane, Fergus, et al.
Publicado: (2023)

Identification of biomarkers of response to preoperative talazoparib monotherapy in treatment naïve gBRCA+ breast cancers
por: Liu, Xuan, et al.
Publicado: (2022)

Barriers to gBRCA Testing in High-Risk HER2-Negative Early Breast Cancer
por: Foroughi, Olivia, et al.
Publicado: (2023)

Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort
por: Peretti, U., et al.
Publicado: (2021)

Timely Genetic Testing and Therapy Management in Patients With gBRCA-Mutated Metastatic Breast Cancer Receiving Talazoparib
por: Martinez, Ashley, et al.
Publicado: (2022)

Association of gBRCA1/2 mutation locations with ovarian cancer risk in Japanese patients from the CHARLOTTE study
por: Yoshihara, Kosuke, et al.
Publicado: (2020)

What Causes Cancer in Women with a gBRCA Pathogenic Variant? Counselees’ Causal Attributions and Associations with Perceived Control
por: Kendel, Friederike, et al.
Publicado: (2022)

All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits
por: Wu, Huai-liang, et al.
Publicado: (2022)

Synchronous Melanoma and Pancreas Malignancies Leading to a Discovery of a CDKN2A Mutation in a Patient with No Known Family History
por: O'Reilly, Mary, et al.
Publicado: (2021)

Correction to: All HER2-negative breast cancer patients need gBRCA testing: cost-effectiveness and clinical benefits
por: Wu, Huai-liang, et al.
Publicado: (2023)

Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey
por: Orsi, G., et al.
Publicado: (2021)

Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover)
por: Puhalla, Shannon L., et al.
Publicado: (2021)

Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study
por: Turner, Nicholas C., et al.
Publicado: (2023)

Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma
por: Zheng-Lin, Binbin, et al.
Publicado: (2022)

Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1
por: Neirich, Leonie, et al.
Publicado: (2021)

Mixed Acinar-Neuroendocrine Carcinoma of the Pancreas with Neuroendocrine Predominance
por: Ogbonna, Onyekachi Henry, et al.
Publicado: (2013)

Solid pseudopapillary neoplasms of the pancreas are dependent on the Wnt pathway
por: Selenica, Pier, et al.
Publicado: (2019)

Neuroendocrine tumor of the pancreas with rhabdoid feature
por: Miyazaki, Tetsuyuki, et al.
Publicado: (2018)

Surgical Management of Neuroendocrine Tumours of the Pancreas
por: Souche, Regis, et al.
Publicado: (2020)

Serotonin-Secreting Neuroendocrine Tumours of the Pancreas
por: Milanetto, Anna Caterina, et al.
Publicado: (2020)

Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls
por: Konukiewitz, Björn, et al.
Publicado: (2021)

Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update
por: Kishore, Sirish A., et al.
Publicado: (2020)

Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas
por: Crowley, Fionnuala, et al.
Publicado: (2022)

Long-molecule scars of backup DNA repair in BRCA1- and BRCA2-deficient cancers
por: Setton, Jeremy, et al.
Publicado: (2023)

Surgical Experiences of Functioning Neuroendocrine Neoplasm of the Pancreas
por: Kang, Chang Moo, et al.
Publicado: (2006)

Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development
por: Huo, Yanying, et al.
Publicado: (2021)

Loss of the BRCA1-PALB2 interaction accelerates p53-associated tumor development in mice
por: Mahdi, Amar H., et al.
Publicado: (2020)

Mixed neuroendocrine-non-neuroendocrine tumour of pancreas mimicking groove pancreatitis: Case report
por: Dhali, Arkadeep, et al.
Publicado: (2021)

Laparoscopic Enucleation of a Nonfunctioning Neuroendocrine Tumor of the Pancreas
por: Kang, Chang Moo, et al.
Publicado: (2008)

Unusual Paraneoplastic Syndrome Accompanies Neuroendocrine Tumours of the Pancreas
por: Bertani, Helga, et al.
Publicado: (2011)

Imaging neuroendocrine tumours of the pancreas: role of CT and MRI
por: Sahdev, Anju
Publicado: (2014)

Pancreatic Neuroendocrine Tumor in the Setting of Dorsal Agenesis of the Pancreas
por: Nassif, Samih, et al.
Publicado: (2016)

Gastric neuroendocrine tumor arising from heterotopic pancreas
por: Tanaka, Takehiro, et al.
Publicado: (2017)

Imitators of chronic pancreatitis: diffuse neuroendocrine tumour of the pancreas
por: Naringrekar, Haresh, et al.
Publicado: (2017)

Neuroendocrine and cardiac metabolic dysfunction and NLRP3 inflammasome activation in adipose tissue and pancreas following chronic spinal cord injury in the mouse
por: Bigford, Gregory E., et al.
Publicado: (2013)

Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML
por: Hart, Steven N., et al.
Publicado: (2020)

BRCA2 Reversion Mutation Identified by Liquid Biopsy After Durable Response to FOLFIRINOX in BRCA2-Associated Pancreatic Cancer
por: Kondo, Tomohiro, et al.
Publicado: (2020)

Complete and durable response of pulmonary large‐cell neuroendocrine carcinoma to pembrolizumab
por: Kadota, Naoki, et al.
Publicado: (2021)

Laparoscopic Enucleation of a Nonfunctioning Neuroendocrine Tumor at the Head of the Pancreas
por: Singh, Nikhil, et al.
Publicado: (2006)

A Rare Case of Mixed Neuroendocrine Tumor and Adenocarcinoma of the Pancreas
por: Xenaki, Sofia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cjsklv6b6g57936042053houca